Primary PCI is the gold standard. Yet, it remains inaccessible to the majority of patients. 1 Delays in primary PCI are common and can result in increased mortality and morbidity. 2 Contrarily, fibrinolytic are easily available, economical, and evaluated in several clinical studies. A pharmaco-invasive approach that is first administering early fibrinolysis and then systematically performing an angiography (and a PCI if needed) is recommended.
1 Patients suffering from ACS are younger (average age 56.3 years) compared to the developed countries and have a higher proportion (>60.6%) of STEMI than patients in developed countries. 3 It is estimated that more than 3 million STEMI occur every year in India. 3 Outcome of patients with STEMI is strongly influenced by the time from symptom onset to successful reperfusion. 2 Pharmaco-invasive therapy is recommended in STEMI patients even in…
